Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Celltrion (068270) – Modification of Listing (Share Retirement) / 2025-04-02 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Decision on Bonus Issue / 2026-07-16 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Extraordinary General Meeting of Shareholders Results / 2025-09-17 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Shinhan Securities | Elevated Earnings Visibility · Disciplined Supply · BUY Rating & Target Price Maintained / 2024-04-26 RESEARCH
  • [Research] Samsung Electro-Mechanics (009150) – Kiwoom Securities | AI Hardware Penetration · High-End MLCC & FC-BGA · Valuation Normalization / 2024-12-17 RESEARCH
  • [Disclosure] Samsung Electro-Mechanics (009150) – Investor Relations (IR) Schedule Announcement / 2026-07-09 Disclosures
  • [Disclosure] Samsung Electronics (005930) – (Correction) Consolidated Earnings Estimate (Disclosure) / 2024-10-31 Semiconductors
  • [Disclosure] ISU PETASYS (007660) – Change in Revenue or Profit/Loss Structure / 2026-01-28 Semiconductors

Category: Disclosures

[Disclosure] Hanwha Systems (272210) – Advance Notice of Financial Results Announcement / 2026-01-22

Posted on January 22, 2026August 10, 2026 By K-STOCK Editor
[Disclosure] Hanwha Systems (272210) – Advance Notice of Financial Results Announcement / 2026-01-22

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems announced that it plans to disclose its provisional financial results for FY2025 on February 6, 2026. 📊 [Key Disclosure Contents & Summary of Key Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Provisional Earnings Disclosure on Scheduled Date This announcement provides advance…

Read More “[Disclosure] Hanwha Systems (272210) – Advance Notice of Financial Results Announcement / 2026-01-22” »

Disclosures, Defense

[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Announcement / 2026-01-22

Posted on January 22, 2026August 10, 2026 By K-STOCK Editor
[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Announcement / 2026-01-22

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems announced that it will host an Investor Relations (IR) conference call and webcast on February 6, 2026, at 15:00 KST to announce its Q4 2025 business results. 📊 [Key Disclosure Contents & Summary of Key Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…

Read More “[Disclosure] Hanwha Systems (272210) – Investor Relations (IR) Announcement / 2026-01-22” »

Disclosures, Defense

[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2026-01-21

Posted on January 21, 2026August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2026-01-21

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Ocean secured a contract worth KRW 738.3B (6.9% of recent annual revenue) to construct two LNG carriers (LNGC) for an Oceanian shipowner. 📊 [Key Disclosure Details & Financial Summary] 1. Contract Overview 2. Financial Details & Scale 3. Contract Terms & Schedule 📝 Editor’s Comment…

Read More “[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2026-01-21” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Earnings Release Advance Notice / 2026-01-21

Posted on January 21, 2026August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Earnings Release Advance Notice / 2026-01-21

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Ocean gave advance notice that it plans to disclose its provisional Q4 2025 financial results on February 4, 2026. 📊 [Key Disclosure Details & Financial Summary] 1. Earnings Release Advance Notice Details 2. Other Important Notes 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring the…

Read More “[Disclosure] Hanwha Ocean (042660) – Earnings Release Advance Notice / 2026-01-21” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – Investor Relations (IR) Presentation / 2026-01-21

Posted on January 21, 2026August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Investor Relations (IR) Presentation / 2026-01-21

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Ocean will hold an Investor Relations (IR) conference call and webcast on February 4, 2026, at 14:00 KST to present its Q4 2025 earnings results. 📊 [Key Disclosure Details & Financial Summary] 1. IR Presentation Overview 2. IR Materials & Additional Details 📝 Editor’s Comment…

Read More “[Disclosure] Hanwha Ocean (042660) – Investor Relations (IR) Presentation / 2026-01-21” »

Disclosures, Shipbuilding

[Disclosure] Celltrion (068270) – Decision on Disposal of Treasury Shares / 2026-01-21

Posted on January 21, 2026August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Decision on Disposal of Treasury Shares / 2026-01-21

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion has decided to dispose of 11,379 common treasury shares (approx. KRW 1.65B) to grant shares following the exercise of stock options by 10 employees. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Treasury Share Delivery Completion and…

Read More “[Disclosure] Celltrion (068270) – Decision on Disposal of Treasury Shares / 2026-01-21” »

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Forecast of Operating Performance (Fair Disclosure) / 2026-01-21

Posted on January 21, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Forecast of Operating Performance (Fair Disclosure) / 2026-01-21

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has officially disclosed its guidance for FY2026 consolidated revenue, targeting KRW 5.32T. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Tracking Actual FY2026 Revenue Performance Against Annual Guidance This disclosure provides the company’s FY2026 revenue guidance based on…

Read More “[Disclosure] Samsung Biologics (207940) – Forecast of Operating Performance (Fair Disclosure) / 2026-01-21” »

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Change in Revenue or Income Structure Exceeding 30% (15% for Large-Scale Corporations) / 2026-01-21

Posted on January 21, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Change in Revenue or Income Structure Exceeding 30% (15% for Large-Scale Corporations) / 2026-01-21

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics disclosed that its FY2025 consolidated revenue increased by 30.3% year-on-year to approximately KRW 4.56T and operating profit rose 56.6% to KRW 2.07T, driven by full operation of Plant 4 and stable operations at Plants 1-3. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s…

Read More “[Disclosure] Samsung Biologics (207940) – Change in Revenue or Income Structure Exceeding 30% (15% for Large-Scale Corporations) / 2026-01-21” »

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Provisional Performance (Fair Disclosure) / 2026-01-21

Posted on January 21, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Provisional Performance (Fair Disclosure) / 2026-01-21

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics disclosed its provisional Q4 2025 consolidated revenue of KRW 1.29T and operating profit of KRW 528.3B, bringing its full-year 2025 cumulative revenue to KRW 4.56T, up 30.3% year-on-year. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Comparing Preliminary…

Read More “[Disclosure] Samsung Biologics (207940) – Provisional Performance (Fair Disclosure) / 2026-01-21” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – Pre-announcement of Earnings Release / 2026-01-20

Posted on January 20, 2026August 9, 2026 By K-STOCK Editor
[Disclosure] Hanwha Aerospace (012450) – Pre-announcement of Earnings Release / 2026-01-20

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Aerospace announced that it plans to release its provisional Q4 and full-year FY2025 financial results on February 9, 2026. 📊 [Key Disclosure Contents & Summary of Figures] [Earnings Announcement Schedule] [Other Key Considerations] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Tracking Scheduled Earnings Disclosure and…

Read More “[Disclosure] Hanwha Aerospace (012450) – Pre-announcement of Earnings Release / 2026-01-20” »

Disclosures, Defense

Posts pagination

Previous 1 … 66 67 68 … 252 Next
  • [Disclosure] Celltrion (068270) – Consolidated Provisional Financial Results / 2025-05-09 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Cash and In-Kind Dividend / 2026-04-23 Disclosures
  • [Disclosure] Jeju Semiconductor (080220) – Securities Issuance Results (Voluntary Disclosure) / 2025-02-26 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | FX Impact · Expanding Next-Gen Revenue · Portfolio Diversification / 2025-06-17 RESEARCH
  • [Disclosure] Samsung Electronics (005930) – Other Major Management Matters (Voluntary Disclosure) / 2024-11-29 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding (Notice) / 2024-09-03 Automotive
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Legacy DRAM Weakness Risk · HBM Growth Deceleration · Target Price Lowered / 2025-04-25 RESEARCH
  • [Disclosure] Wonik IPS (240810) – Decision on Calling of General Shareholders’ Meeting / 2026-07-24 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme